Bonus Share Activity Gains Attention
Corporate actions such as bonus share issues continue to attract attention in the equity markets, particularly when multiple companies announce them within a short period. In May 2026, a few listed firms have lined up bonus issuances, each with distinct ratios and timelines.
Bonus shares are issued by companies to existing shareholders by capitalising their reserves. While this does not change the overall value of an investor’s holdings immediately, it increases the number of shares held, thereby adjusting the share price proportionately.
Key Bonus Announcements for May 2026
Among the companies announcing bonus issues this month, Alka India Ltd has declared one of the most generous ratios. The company has set a bonus ratio of 6:1, meaning shareholders will receive six additional shares for every one share held. Both the ex-date and record date for this issue fall on May 8, 2026.
Aptus Pharma Ltd has announced a bonus issue in the ratio of 3:2. Under this structure, shareholders will receive three additional shares for every two shares owned. The ex-date and record date for this corporate action are scheduled for May 12, 2026.
Biogen Pharmachem Industries Ltd has declared a 1:6 bonus ratio, where shareholders will receive one additional share for every six shares held. The relevant dates for this issue are set for May 15, 2026.
These announcements highlight a range of bonus structures, reflecting different approaches by companies in distributing accumulated reserves.
How Bonus Ratios Work
The bonus ratio determines the number of additional shares allotted to shareholders. A higher ratio results in a greater increase in the number of shares held. For example, a 6:1 ratio significantly expands shareholding, while a 1:6 ratio results in a relatively smaller addition.
Despite the increase in share count, the overall investment value remains broadly unchanged immediately after the issue, as the stock price is adjusted to reflect the higher number of shares in circulation.
Importance of Ex-Date and Record Date
Two key dates play a crucial role in bonus share eligibility: the ex-date and the record date. The ex-date marks the day from which the stock starts trading without the entitlement to bonus shares. Investors who purchase shares on or after this date are not eligible for the bonus issue.
The record date is used by the company to identify eligible shareholders who will receive the bonus shares. To qualify, shareholders must hold the stock before the ex-date so that their names appear in the company’s records on the record date.
In the case of the May 2026 announcements, the ex-date and record date coincide for each company, simplifying the eligibility timeline.
Impact on Shareholding and Market Activity
Bonus issues often lead to an increase in the number of shares available in the market, which can enhance liquidity. A larger number of shares in circulation may encourage higher trading volumes and broader participation.
These corporate actions also reflect a company’s decision to utilise accumulated reserves in a way that rewards existing shareholders. While the immediate financial value remains unchanged, the increased share count can influence market perception and trading behaviour.
Conclusion
The bonus share announcements scheduled for May 2026 underline active corporate developments among select companies. With varying ratios and clearly defined timelines, these issuances will reshape shareholding structures and potentially influence market activity. As companies continue to use bonus shares as a mechanism to distribute reserves, such corporate actions remain a notable feature of the equity landscape.
Summary
Several companies, including Alka India Ltd, Aptus Pharma Ltd, and Biogen Pharmachem Industries Ltd, have announced bonus share issuances scheduled for May 2026. These corporate actions will increase the number of outstanding shares without requiring additional investment from shareholders. With varying bonus ratios and aligned ex-dates and record dates, these announcements are expected to influence trading activity and shareholding patterns in the near term.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.
